LUYE PHARMA (02186.HK) announced that all conditions precedent for the issuance of USD 50 million convertible Bonds with a 5.85% interest rate maturing in 2025 have been met, and the issuance of the related Bonds has been successfully completed. It is expected that the related Bonds will be listed on the Singapore Exchange today (16th).
LUYE PHARMA stated that this issuance can improve the group's liquidity and replace part of the short-term loans, and the net proceeds from the Bond issuance will reduce the group's capital costs and improve the debt maturity situation. (js/w)
~